Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VNN1 | O95497 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27602 | 0.89 | GABRB3 (0.39) | VNN1 | |
| SCHEMBL16116607 | 0.89 | VNN1 (0.31) | VNN1 | |
| SCHEMBL13892510 | 0.81 | GABRB3 (0.46) | VNN1 | |
| Pyriprole SCHEMBL19032727 | 0.80 | GABRP (0.35) | VNN1 | |
| SCHEMBL5220491 | 0.79 | GABRB3 (0.40) | VNN1 | |
| SCHEMBL5217113 | 0.79 | GABRB3 (0.40) | VNN1 | |
| SCHEMBL16118103 | 0.78 | GABRB3 (0.41) | VNN1 | |
| SCHEMBL14208642 | 0.78 | GABRP (0.39) | — | |
| SCHEMBL678058 | 0.77 | KDM4E (0.38) | — | |
| SCHEMBL4854540 | 0.74 | GABRP (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160044921-A1 | SYNERGISTIC ACTIVE INGREDIENT COMBINATIONS | BAYER CROPSCIENCE AG (DE) | 2016-02-18 | — | — | US | disclosed |
| US-20140287915-A1 | SYNERGISTIC ACTIVE INGREDIENT COMBINATIONS | BAYER CROPSCIENCE AG (DE) | 2014-09-25 | — | — | US | disclosed |
| US-20110275583-A1 | Synergistic active compound combinations | BAYER CROPSCIENCE AG (DE) | 2011-11-10 | — | — | US | disclosed |
| US-20110124588-A1 | SYNERGISTIC ACTIVE INGREDIENT COMBINATIONS | BAYER CROPSCIENCE AG (DE) | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160044921-A1 | SYNERGISTIC ACTIVE INGREDIENT COMBINATIONS | ACHE, ACAT2, ACAT1 | VNN1 2827/4885 |
| US-20110124588-A1 | SYNERGISTIC ACTIVE INGREDIENT COMBINATIONS | ACHE, ACAT2, ACAT1 | VNN1 2827/4885 |
| US-20140287915-A1 | SYNERGISTIC ACTIVE INGREDIENT COMBINATIONS | ACHE, ACAT2, ACAT1 | VNN1 2827/4885 |
| US-20110275583-A1 | Synergistic active compound combinations | ACHE, ACAT2, ACAT1 | VNN1 3793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.